Monthly Archives: November 2017

FDA Latest Industry Guidance for Liposome Drug Products

Liposome Drug Products Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation Guidance for Industry It provides specific labeling requirements for liposome versus pegylated liposome. The nonproprietary name of a drug product approved under the Federal Food, Drug, … Continue reading

Posted in Blogs | 1 Comment